After discussions with the FDA, Moderna has withdrawn its application for a combination shot, which had demonstrated efficacy in eliciting antibodies in data announced earlier this month.

The FDA will make it more costly to seek approval of Covid-19 vaccines, but Moderna's shareholder reacted favorable to the ...

THURSDAY, May 8, 2025 (HealthDay News) — A new vaccine that combines flu and COVID ... Moderna said it now expects that approval of the shot may not come until 2026. “I agree in this case ...

The mRNA technology is used in approved COVID-19 and RSV shots, but has not yet been approved for a flu shot. Moderna believes ... “I agree in this case with FDA that efficacy data are important ...